When it comes to your health, only the best will do. That’s why we’ve spent years mastering the science of CBD genetics and production to bring you a safe and powerful proprietary formula, complete with a satisfaction guarantee


Derived from single-sourced American hemp, VictisCBD is one of the few CBD brands in America to own its entire supply chain — which means we oversee our production from top to bottom.

Our organic, pharmaceutical-grade CBD products have been tested by an accredited third-party to ensure efficacy, safety, and accuracy for you and your family. Produced in our own processing centers and laboratories, VictisCBD is developed with the highest quality standards and most advanced science for consistent and effective pain relief every time.


Victis owns and operates its own certified cultivation and processing facilities in Nevada and North Carolina. Product safety, availability, and traceability are important to us, which is why we invest heavily in geographical redundancy of our wholly owned, seed-to-shelf operations. In fact, unlike the majority of CBD retailers, we cultivate and harvest fresh, organic hemp plants weekly instead of allowing them to degrade in a warehouse. Additionally, Victis is active in multiple non-GMO, natural plant research programs, which allows us to safely maximize our plant’s therapeutic benefits. By 2021, Victis will have large-scale sites and facilities open in Arizona, South Carolina, and Florida.

Victis is led by healthcare industry veterans

Dr. Michael LaCount and Zeb Portanova

DR. Michael Lacount

Dr. Mike LaCount is Founder and CEO of Yield Scientific as well as Advising Managing Director at Frontcourt, a leading boutique healthcare and technology investment bank. He previously served as President and CEO at Arcus Medical, and as Interim CEO, Managing Director, and Vice Chairman for Elauwit. Mike has completed research fellowships with Wyeth-Ayerst Laboratories, Procter and Gamble Pharmaceuticals, and the Computational Crystallography Group at the Pittsburgh Supercomputing Center. He earned his Doctorate in Chemistry from the University of South Carolina and holds a B.S. in Chemistry from the State University of New York.


Zeb Portanova is President of Yield Scientific and CEO of GEM Opportunity Zone Fund, an impact investment fund focused on opportunity zones in the USA. He was previously COO for Vestergaard, a global health company focused on malaria prevention and public health, and President / CEO of Swiss KRONO USA. Zeb has served on numerous boards of directors including the UN Global Compact Switzerland, Habitat for Humanity, and the Southern Carolina Regional Development Alliance. He earned his MBA from Duke University, a Master’s in Public Policy from Harvard University, and a Bachelor’s Degree from the University of Florida.

Ready to experience the Victis difference for yourself?